Tamoxifen evolution

Howell, Anthony; Howell, Sacha J

dc.contributor.author	Howell, Anthony
dc.contributor.author	Howell, Sacha J
dc.date.accessioned	2023-03-20T15:43:59Z
dc.date.available	2023-03-20T15:43:59Z
dc.date.issued	2023	en
dc.identifier.citation	Howell A, Howell SJ. Tamoxifen evolution. British journal of cancer. 2023 Feb;128(3):421-5. PubMed PMID: 36765172. Pubmed Central PMCID: PMC9938251. Epub 2023/02/11. eng.	en
dc.identifier.pmid	36765172	en
dc.identifier.doi	10.1038/s41416-023-02158-5	en
dc.identifier.uri	http://hdl.handle.net/10541/626059
dc.description.abstract	None	en
dc.language.iso	en	en
dc.relation.url	https://dx.doi.org/10.1038/s41416-023-02158-5	en
dc.title	Tamoxifen evolution	en
dc.type	Article	en
dc.contributor.department	Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.	en
dc.identifier.journal	British Journal of Cancer	en
dc.description.note		en]
refterms.dateFOA	2023-03-21T09:30:28Z